Attraction of Medical Education Research

The study is based on research participants in experiments in 1990 in Montreal General Hospital and Loma Linda University Medical educational research School in California. This study compared the results of two different doses of radiation for prostate cancer in the country to deal with. All participants received a dose of X-ray therapy and a booster proton therapy based on the full dose at all levels of the standard 70 Gy or 79 Gy, which is now performed similar to the dose of cancer. Proton therapy reduces the irradiation of normal tissue obtained before and after the tumor and the X-ray therapy and minimization of radiation were given to normal tissue. Previous studies have shown that five years after treatment with the maximum radiation dose to the tumor recurrence reduced by almost half, the front, he was only nine years after treatment. participating physicians reported the same low level of toxicity associated with the treatment in both groups but the patients do not even questioned about their experiences after the operation. The current study was to examine the relationship between the participants educational research their experience at the lowest side effects. Researchers will be sent to all participants to a questionnaire that a standard evaluation of urinary, bowel and sexual symptoms were generally to the treatment of prostate cancer to survive. Further evaluation of specific symptoms were asked the participants to their role in the assessment of normal, regular or bad. They were also about their attitudes towards the current state of health and cancer treatment decisions they made bat. The study included 280 398 participants in the original study, divided into groups with high-dose and standard media. Both groups were so low, side effects of treatment and quality of life. Patients in the standard dosage - which is a higher incidence of relapse is often necessary with other treatments - the conviction that the tumors less strict and more suffering choice of treatment, which had to register in this case, randomized studies. Ranking participants stool and urine in the sex often better than on the basis of the symptoms to be expected. Jack Szostak is a researcher at the Howard Hughes Medical School, Professor of Genetics at Harvard Medical School, and Alex Rico prominent scientists Department of Molecular Biology, Massachusetts General Hospital. Awarded 2009 Nobel Prize in Medicine to find telomerase enzyme that protects chromosomes from degradation, a common educational research process of aging and various disease states. Received the 2006 Lasker Basic Medical Research for their further research focus of the laboratory synthesis of self-replicating systems work.His and the origin of life. He and his colleagues have developed an in vitro selection tool for the isolation of rare functional RNA-DNA and protein molecules with large collections of random sequences. His laboratory was to isolate for in vitro selection and directed evolution and describe a number of specific nucleic acid-binding properties of the ligand and catalyst. E ', co-director of the Harvard Origins of Life. " Szostak was Gerald Joyce, Scripps Research Institute in 1994, the National Academy of Sciences Award in Molecular Biology, 1997 and Sigrist Prize, University of Bern, Switzerland. Member of the National Academy of Sciences, member of the New York Academy of Sciences and the American Academy of Arts and Sciences. In 2000, the Medal of Szostak Genetics Society Paegel America.Brian assistant professor in the Department of Chemistry, is to develop cooperation with the Scripps Translational Research Institute in Florida, and Scripps Research Institute headquartered in La Jolla, California. It is good for his work in the directed evolution, Darwin's principle of the population of molecules, rather than the authorities and the use of micro-channel technology platform to molecules in real-time search School of Medicine Monitor known. Paegel graduated with honors and studied chemistry at Duke University (North Carolina) in 1998 and a doctorate in chemistry at the University of California, Berkeley, December 2003. Immediately before the arrival of Scripps Florida in 2008, the National Institutes of Health Research Fellow in the laboratory Gerald Joyce at the Scripps Research in La Jolla campus. He received the National Institutes of Health grant Independence Road, 2007.